Sinopharm
1099.HK
#1896
Rank
โ‚น720.04 B
Marketcap
โ‚น230.74
Share price
2.90%
Change (1 day)
10.37%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2023 (TTM): โ‚น5.089 Trillion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is โ‚น6.750 Trillion. In 2022 the company made a revenue of โ‚น6.750 Trillion a decrease over the revenue in the year 2021 that were of โ‚น6.894 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) โ‚น5.089 T-24.6%
2022 โ‚น6.750 T-2.1%
2021โ‚น6.894 T16.85%
2020โ‚น5.900 T14.95%
2019โ‚น5.132 T21.52%
2018โ‚น4.223 T5.93%
2017โ‚น3.987 T27.22%
2016โ‚น3.134 T5.37%
2015โ‚น2.974 T9.14%
2014โ‚น2.725 T17.22%
2013โ‚น2.324 T25.94%
2012โ‚น1.845 T34.61%
2011โ‚น1.371 T55.34%
2010โ‚น882.80 B35.79%
2009โ‚น650.13 B37.56%
2008โ‚น472.62 B31.43%
2007โ‚น359.61 B40.26%
2006โ‚น256.38 B